News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Canada’s Angiotech Pharmaceuticals, Inc. to File for Bankruptcy
January 28, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Jan 28 (Reuters) - Angiotech Pharmaceuticals Inc (ANP.TO) said it will file for bankruptcy protection under Canada's Companies' Creditors Arrangement Act to cut $250 million of its debt.
Twitter
LinkedIn
Facebook
Email
Print
Bankruptcy
MORE ON THIS TOPIC
Layoff Tracker
BMS Closes Manufacturing Plant, Arvinas Axes One-Third of Staff
May 2, 2025
·
185 min read
·
BioSpace Editorial Staff
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
·
3 min read
·
Annalee Armstrong
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
·
5 min read
·
Annalee Armstrong
IPO
Swiss ADC Biotech Takes SPAC Track to NASDAQ
April 23, 2025
·
1 min read
·
Annalee Armstrong
